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Background: Clustered regulatory interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9
(Cas9)-mediated genome editing permits the rapid production of genetically engineered mice. To make the most of
this innovative technology, a streamlined procedure is needed for the robust construction of CRISPR/Cas9 vectors, the
efficient preparation of mouse oocytes, and refined genotyping strategies. Although we previously demonstrated the
applicability of oocyte cryopreservation technologies and various genotyping methods in the production of
transcription activator-like effector nuclease-mediated genome editing in mice, it has not yet been clarified whether
these techniques can be applied to the CRISPR/Cas9-mediated generation of knockout mice. In this study, we
investigated easy, efficient, and robust methods of creating knockout mice using several CRISPR/Cas9 systems.
Results: We constructed three types of CRISPR/Cas9 vectors expressing: 1) single guide RNA (gRNA) and Cas9 nuclease,
2) two gRNAs and Cas9 nickase, and 3) two gRNAs and FokI-dCas9, targeting the same genomic locus. These vectors
were directly microinjected into the pronucleus of freeze-thawed fertilized oocytes, and surviving oocytes were
transferred to pseudopregnant ICR mice. Cas9 nuclease resulted in the highest mutation rates with the lowest
birth rates, while Cas9 nickase resulted in the highest birth rates with the lowest mutation rates. FokI-dCas9
presented well-balanced mutation and birth rates. Furthermore, we constructed a single all-in-one FokI-dCas9
vector targeting two different genomic loci, and validated its efficacy by blastocyst analysis, resulting in highly
efficient simultaneous targeted mutagenesis.
Conclusions: Our report offers several choices of researcher-friendly consolidated procedures for making CRISPR/
Cas9-mediated knockout mice, with sophisticated construction systems for various types of CRISPR vectors, convenient
preparation of in vitro fertilized or mated freeze-thawed oocytes, and an efficient method of mutant screening.
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Genetically engineered mice (GEM) have played an es-
sential part in elucidating the functions of specific genes,
the mechanisms of disease, embryogenesis and differen-
tiation over recent decades. Although massive numbers
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unless otherwise stated.the world [1], there is still a demand for more efficient
methods of generating de novo GEM.
Genome editing using programmable nucleases, such
as zinc-finger nucleases (ZFNs), transcription activator-
like effector nucleases (TALENs), and clustered regu-
larly interspaced short palindromic repeats (CRISPR)/
CRISPR-associated protein 9 (Cas9), is an easy and effi-
cient strategy to generate GEM [2]. In particular, CRISPR/
Cas9 provides the most convenient method by which to
produce GEM because of its simple construction and high
DNA double-strand break (DSB)-inducing activity [3]. Atral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ase and a single guide RNA (gRNA) that targets a speci-
fied genomic locus containing a 20-base sequence defined
by the gRNA and a protospacer adjacent motif (PAM)
sequence defined by Cas9, the complex then cleaves
the double-stranded DNA. DSBs are mainly repaired by
error-prone non-homologous end-joining (NHEJ), ran-
domly inducing insertions and/or deletions, which cause
targeted gene disruption.
The conventional CRISPR/Cas9 complex does not form
a dimer, unlike ZFNs and TALENs, and it often leads to
off-target mutations with high frequency [4-6]. Although
the frequencies of off-target mutations in animal embryos,
especially in mice and rats, are reportedly not so high [7,8],
they do exist and therefore present a potential risk even in
animals. To improve the specificity, two derivative tech-
nologies have been developed; double-nicking using Cas9
nickase [9-13] and FokI-dimerization using nuclease-
deficient Cas9 fused to FokI (FokI-dCas9) [14,15]. In both
strategies, paired gRNAs are used to recruit two molecules
of Cas9 nickase or FokI-dCas9 on juxtaposed positions
of the target genomic locus, resulting in DNA cleavage.
Importantly, single gRNA-guided Cas9 nickase can only
induce a nick, which is less mutagenic than a DSB. Further-
more, single gRNA-guided FokI-dCas9 does not damage
the genomic DNA at all. Therefore, off-target mutations
are significantly reduced in these two derivative strategies.
To generate knockout mice using the CRISPR/Cas9
system, Cas9 mRNA and gRNA are generally synthe-
sized using in vitro transcription and used for micro-
injection [16-21]. However, Mashiko and colleagues
described a simplified protocol using pronuclear micro-
injection of circular plasmid expressing Cas9 and a
gRNA [7,22]. Direct use of plasmids avoids the need for
laborious in vitro transcription and purification steps,
and plasmids offer high stability compared with RNAs
enabling the robust production of knockout mice. In
addition, we recently established an all-in-one CRISPR/
Cas9 vector system for the assembly of multiple gRNA
cassettes and a Cas9 nuclease/nickase cassette in a single
vector [23]. When combined with these procedures, effi-
cient production of knockout mice mediated by paired
gRNA-guided CRISPR systems has been thought to be
achieved.
Regarding the preparation of oocytes for microinjection
to generate knockout mice with genome editing technolo-
gies, fertilized oocytes were usually collected by mating a
male mouse and a superovulated female mouse. However,
preparing fresh fertilized oocytes for every experiment is
time-consuming and laborious work. We have previously
established a procedure of using freeze-thawed fertilized
oocytes created by in vitro fertilization (IVF) for the
TALEN-mediated generation of knockout mice [24], as
well as previous reports of transgenic mouse production[25,26]. In addition, Li and colleagues recently reported
that fresh fertilized oocytes created by IVF could be used
for conventional CRISPR/Cas9-mediated mouse genome
editing [21]. However, Han and colleagues reported that
they failed to produce genome edited mice by pronuclear
injection of CRISPR/Cas9 plasmid, while cytoplasmic in-
jection of Cas9 mRNA and purified gRNA resulted in suc-
cessful genome editing [27]. Thus, the applicability of
cryopreservation and IVF technologies for various CRISPR
systems is another important advance in establishing the
streamlined CRISPR/Cas9 plasmid injection-mediated
production of knockout mice.
Here, we expand the multiplex gRNA assembly system
to include FokI-dCas9, and construct Cas9 nuclease-,
Cas9 nickase- and FokI-dCas9-type vectors for the gen-
eration of knockout mice. The gRNAs for each system
are designed to target the same locus of an endogenous
gene, and comparisons of the birth rate and the muta-
tion rate are conducted. The applicability of cryopreser-
vation and IVF is also investigated. We further examined
whether pronuclear injection of a single all-in-one plas-
mid expressing FokI-dCas9 and four gRNAs could
achieve multiplex genome editing in mouse embryos.
Results and discussion
Construction of an all-in-one vector system for FokI-dCas9-
mediated genome editing
We previously established a system for creating all-in-one
CRISPR/Cas9 vectors expressing Cas9 nuclease or nickase
and up to seven gRNAs [23], and have distributed these
plasmids as a “Multiplex CRISPR/Cas9 Assembly System
Kit” via Addgene (Kit #1000000055). To expand the sys-
tem for FokI-dCas9-mediated genome editing, we first
created pX330A_FokI-1x(2–7) vectors. Using these newly
constructed plasmids and pX330s-(2–7) vectors included
in the Addgene Kit, we can create an all-in-one vector for
FokI-dCas9-mediated genome editing, not only for single
but also for multiplex gene editing (Figure 1). The new
vectors will expectedly be distributed by Addgene as a
supplemental package of the current kit (Multiplex
CRISPR dCas9/FokI-dCas9 Accessory Pack).
Design of CRISPR/Cas9 nuclease, Cas9 nickase, and
FokI-dCas9 vectors to target the interleukin-11 (IL11) gene
To compare the applicability of the three CRISPR/Cas9
systems with Cas9 nuclease, Cas9 nickase, or FokI-dCas9
in mouse genome editing, we designed and constructed
CRISPR/Cas9 vectors as shown in Figure 2. Although the
three systems require different design parameters and it is
difficult to compare the genome editing efficacy with
exactly the same gRNAs, we tried to target almost the
same genomic region, which is around exon 3 of the
IL11 gene. For Cas9 nuclease, two gRNAs, gRNA_A
and gRNA_B, were designed within the exon and
Figure 1 Schematic illustration of the all-in-one FokI-dCas9 vector construction system. Single gRNA-expressing vectors are constructed by
the insertion of annealed oligonucleotides. Subsequently, the gRNA cassettes are assembled using Golden Gate cloning. Amp, ampicillin; Spec,
spectinomycin; U6, human U6 promoter; CBh, chicken beta-actin short promoter.
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(Figure 2A; Nuclease_A and Nuclease_B vectors). For
Cas9 nickase, gRNA_B and gRNA_C were designed
with a 7-bp offset (Figure 2B: Nickase_BC vector).
When inducing double nick-mediated genome modifica-
tion, the optimal range of the offset length is around 0–
10 bp [23], whereas FokI-dCas9 requires 13- to 18-bp
offsets for highly-efficient targeted mutagenesis [14].
Thus, we designed another gRNA, gRNA_D, in com-
bination with gRNA_B for FokI-dCas9 (Figure 2C;
FokI-dCas9_BD vector).
Activity validation of the all-in-one FokI-dCas9 vector
Since the genome editing potential of the all-in-one vector
containing the FokI-dCas9 cassette was unknown, we
evaluated the activity of the FokI-dCas9_BD vector in
mouse embryos. The FokI-dCas9_BD vector was microin-
jected into the pronucleus of mouse fertilized oocytes.
Twenty-one survival oocytes were cultured for 3.5 days.
We observed seven blastocysts, and six of these embryos
developed into expanded blastocysts. Each blastocyst wascollected into a microtube, and then PCR was performed
to amplify the targeted locus. We verified that at least one
mutation had been induced in three embryos by direct se-
quencing (Figure 3A). In addition, bacterial cloning of the
PCR products followed by DNA sequencing revealed high
mutation rates (≥50%) (Figure 3B), confirming the power-
ful potential of the all-in-one FokI-dCas9 vector for GEM
generation.
GEM generation by microinjection of all-in-one CRISPR/
Cas9 plasmids into freeze-thawed fertilized oocytes
We next conducted microinjection of the three types of
CRISPR/Cas9 vectors into freeze-thawed fertilized oo-
cytes for efficient and convenient genome engineering in
mice. Using reproductive engineering techniques, such
as IVF and freeze-thawing, fertilized oocytes could be
obtained with high efficiency (Additional file 1). Each
CRISPR/Cas9 vector was directly injected into the pro-
nucleus of freeze-thawed fertilized oocytes prepared by
mating or IVF. The survival oocytes after microinjection
were transferred into the oviducts of pseudopregnant
Figure 2 The target sequence and the constructed vectors. The genomic region around exon 3 of the IL11 gene was targeted by Cas9 nuclease
(A), Cas9 nickase (B), or FokI-dCas9 (C) vectors. The target sequence of each gRNA is indicated by colored bases. The PAM sequence is underlined.
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birth to pups (Table 1), and all the pups excluding one
pup died from cannibalism were genotyped by direct se-
quencing analysis (Table 1 and Additional file 2). Al-
though we have shown that the combinatorial screening
strategy is required for complete genotyping [28], directsequencing is reportedly able to screen mutant mice
with high mutation rates [7].
Sequencing analysis revealed that all three types of
CRISPR/Cas9 vectors could produce mutant mice, but
the birth rates and mutation rates of each method were
not comparable. In the Cas9 nuclease group, the birth
Figure 3 Sequence analysis of blastocysts injected with the FokI-dCas9_BD vector. The PCR products were analyzed by direct sequencing
(A), followed by sequencing of subcloned plasmids (B). The wild-type IL11 sequence is shown at the top (Wild) with the gRNA target sequences
(underlined). The PAM sequence is enclosed in red boxes. Deletions are indicated by dashes and substitutions and insertions are enclosed in a
black box. A blue box indicates the partial sequence of exon 3. Only one or two types of mutations were detected in direct sequencing (A),
whereas various mutation patterns were observed in subcloned sequencing (B). Numbers in red letters on the right side of each sequence indicate
the frequencies of the corresponding alleles (number of the allele/number of total clones).
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tion rates were high (80–100%). Conversely, more pups
were born in the Cas9 nickase group (19.1% and 22.2%),
while the number of mutants were fewer than in the
Cas9 nuclease group (5.9% and 0%). Interestingly, the
FokI-dCas9 group exhibited moderate birth rates (18.2%
and 17.6%) and mutation rates (66.6% and 33.3%). To
confirm the superiority of FokI-dCas9-mediated method,
we additionally injected the FokI-dCas9_BD vector into
freeze-thawed fertilized oocytes collected from matureTable 1 Generation of IL11 mutants using freeze-thawed ferti
Method Vector Injected Survived
Mating Nuclease_A 76 54 (71.1)
Nuclease_B 72 55 (76.4)
Nickase_BC 108 94 (87.0)
FokI-dCas9_BD 55 46 (83.6)
FokI-dCas9_BD 58* 55 (94.8)
IVF Nuclease_A 32 25 (78.1)
Nuclease_B 34 22 (64.7)
Nickase_BC 32 27 (84.4)
FokI-dCas9_BD 39 35 (89.7)
Numbers in brackets represent percentages.
*Fertilized oocytes were collected from females at 8 weeks of age, whereas 5-week
by mating.female mice (8 weeks of age) mated with male mice.
Consistent with the results using the oocytes collected
from immature female mice (5 weeks of age), the birth
rate and the mutation rate were sufficiently high (38.2%
and 84.6%, respectively). These results suggest not only
the robustness of FokI-dCas9-mediated mouse genome
editing, but also the applicability of oocytes from female
mice at various weeks of age, as shown previously using
TALENs [24]. Although these results do not necessarily
reflect the general properties of the three CRISPR/Cas9lized oocytes
Transferred Pups Analyzed Mutants
54 4 (7.4) 4 4 (100)
55 5 (9.1) 5 4 (80.0)
94 18 (19.1) 17 1 (5.9)
33 6 (18.2) 6 4 (66.6)
34 13 (38.2) 13 11 (84.6)
25 3 (12.0) 3 3 (100)
22 2 (9.1) 2 2 (100)
27 6 (22.2) 6 0 (0)
34 6 (17.6) 6 2 (33.3)
-old females were used for the other injections that oocytes were fertilized
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CRISPR/Cas9-mediated GEM generation. Importantly, the
low birth rates of Cas9 nuclease plasmid-injected mice are
comparable with previous studies using inbred strains
[29,30], although high birth rates can be achieved using
B6D2F1 (BDF1) hybrid mice [7]. We thus concluded that
FokI-dCas9 plasmid injection might be a powerful strategy
for generating knockout mice, especially for inbred strains.
Transgene analysis and off-target analysis
Since plasmid DNA was used for microinjection, we in-
vestigated whether DNA vectors were integrated into
the genome. Genomic PCR of the coding sequence of
Cas9 variants and FokI was performed to detect genomic
integrants. In the two founders generated by the injec-
tion of Nuclease_B vector, the Cas9 gene fragment was
amplified (Additional file 3). Altogether, 10% (2/20) of
the mutant mice carried the transgene. Although the ob-
served transgenicity is slightly higher than in Mashiko’s
report (4.3%) [7], this may not be a major issue because
the transgene can be removed by mating before expan-
sion of the mutant strain.
Finally, potential off-target sites for each gRNA target
site were analyzed by direct sequencing. The top three
candidates for each site were selected using the CRISPR
design tool (http://crispr.mit.edu/) (Additional file 4). We
then sequenced all of the 20 founders (seven founders for
Nuclease_A, six founders for Nuclease_B, one founder for
Nickase_BC, and six founders for FokI-dCas9_BD), but no
off-target mutations were detected. However, our analysis
and all of the previously reported off-target analyses in
mice provide limited genomic context, and the potential
risk of off-target mutagenesis in disparate parts of the
genome is undeniable. In fact, Tsai and colleagues recently
revealed that CRISPR/Cas9 can induce various genomic
rearrangements including megabase-scale large deletions
and chromosomal translocations in cultured cells [31].
They also showed that most of these experimentally
demonstrated off-target sites were not identified as off-
target candidates using any computational prediction
tool including the CRISPR design tool. Also in mice,
these concealed off-target effects can exist, but they are
difficult to detect because they cannot be predicted by
in silico analysis. We thus believe that a highly specific
gene targeting strategy, such as FokI-dCas9, is import-
ant not only for cultured cell applications but also for
the creation of GEM.
Multiplex genome editing in mouse embryos using a
single all-in-one FokI-dCas9 vector
We finally examined whether multiple gene targeting
could be applied using microinjection of a single all-in-
one FokI-dCas9 vector simultaneously expressing four
gRNAs and FokI-dCas9. We designed gRNAs to targetexon 3 of regenerating islet-derived 3 beta (Reg3b) and
regenerating islet-derived 3 gamma (Reg3g) genes, which
are located in the chromosome 6 with 96.1-kb distance
(Figure 4A and B). The all-in-one FokI-dCas9 vector was
microinjected into the pronucleus of fertilized oocytes.
Twenty-eight survival oocytes were cultured for 3.5 days,
and nine embryos developed into expanded blastocysts.
Each blastocyst was collected into a microtube, and then
PCR was performed to amplify around the both target
loci. Direct sequencing analyses revealed that more than
50% of the embryos possessed mutated alleles in the both
target loci (8/9 in Reg3b and 5/9 in Reg3g) (Figure 5A and
B). More importantly, five embryos (#1, 3, 6, 7, and 8) pos-
sessed mutations in the both genes, showing high potential
for creating double knockout mice mediated by microinjec-
tion of all-in-one FokI-dCas9 vector. We further performed
out-out PCR to investigate whether chromosomally deleted
alleles exist, but no intended amplicons were observed
using blastocyst PCR genotyping. Further examinations are
needed to clarify the possible existence of chromosomally
deleted alleles in pups.
Conclusions
Our study compared the genome editing efficiency in one-
cell mouse embryos microinjected with various CRISPR/
Cas9 vectors expressing gRNA(s) and Cas9 nuclease, Cas9
nickase, or FokI-dCas9, constructed by an all-in-one vec-
tor system. In addition, we demonstrated the applicability
of IVF and freeze-thawing of oocytes in GEM generation
mediated by the methods described above, which makes
preparation of fertilized oocytes more convenient. Our
findings suggest that the FokI-dCas9-mediated approach
is a highly reliable strategy for creating GEM, including
double knockout mice, and we provide accessible plat-
forms for the CRISPR/Cas9-based generation of GEM.
Methods
Plasmids
All-in-one CRISPR/Cas9 vectors for Cas9 nuclease and
nickase were constructed using the Multiplex CRISPR/
Cas9 Assembly System Kit (Addgene, Cambridge, MA,
USA; Kit #1000000055) as previously described [23].
For FokI-dCas9 vectors, a H840A mutation was intro-
duced in pX330A_D10A vectors using inverse PCR and
the In-Fusion cloning method (Clontech, Palo Alto,
CA, USA) (pX330A_dCas9 vectors). Subsequently, the
coding sequence of FokI was amplified by PCR from
ptCMV-136/63-VR vector contained in the Platinum
Gate TALEN Kit (Addgene; Kit #1000000043) [32] using
the FokI-dCas9-ins-F and FokI-dCas9-ins-R primers listed
in Additional file 5. The amplified fragment was cloned
using the In-Fusion cloning method into pX330A_dCas9
vectors, which were amplified by inverse PCR using
the FokI-dCas9-vec-F and FokI-dCas9-vec-R primers
Figure 4 Schematic design of multiple gene targeting using all-in-one FokI-dCas9 vector. (A) The genomic context around the targeted loci. The
target sites are located in exon 3 of Reg3b and Reg3g genes. (B) The target sequence and the constructed vectors. The target sequence of each
gRNA is indicated by colored bases. The PAM sequence is underlined.
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struction of pX330A_FokI vectors, oligonucleotides were
inserted and Golden Gate cloning was performed as previ-
ously described [23] to construct the FokI-dCas9_BD
vector.
Animals
All animal experiments were approved by the Animal
Care and Experimentation Committee of the Center for
Animal Resources and Development, Kumamoto Uni-
versity, and were carried out in accordance with the
approved guidelines.
IVF and freeze-thawing of fertilized oocytes
The IVF and freeze-thawing procedure was performed ac-
cording to a previous report [24]. The cauda epididymides
were obtained from C57BL/6 male mice over 12 weeks of
age, and spermatozoa were suspended in FERTIUP® Mouse
Sperm Preincubation Medium (Kyudo, Saga, Japan). Sub-
sequently, the sample was incubated for 1 h at 37°C in 5%
CO2 and 95% humidified air until insemination. C57BL/6
female mice were superovulated using 7.5 IU of pregnant
mare serum gonadotropin (Serotropin; Aska Pharmaceut-
ical, Tokyo, Japan) and 7.5 IU of human chorionic gonado-
tropin (Gonatropin; Aska Pharmaceutical, Tokyo, Japan) at
8–12 weeks of age, and their oviducts were transferred to
fertilization dishes containing a drop of CARD MEDIUM(Kyudo, Saga, Japan). The cumulus-oocyte complexes were
introduced into the drop of CARD MEDIUM. After prein-
cubation of the fresh sperm, the sperm suspension was
added to the drop containing cumulus-oocyte complexes.
The fertilization dishes were incubated at 37°C in 5% CO2
and 95% humidified air. After 3 h, the inseminated oocytes
were rinsed three times with human tubal fluid medium.
After 2 h, the oocytes were cryopreserved by a simple
vitrification method [33,34]. At later time points, the cryo-
preserved oocytes were thawed by a thawing method for
vitrified oocytes using warmed PB1 containing 0.25 M
sucrose [33,34]. The freeze-thawed oocytes were used
for microinjection.
Mating and freeze-thawing of fertilized oocytes
C57BL/6 female mice were induced to superovulate
using pregnant mare serum gonadotropin and human
chorionic gonadotropin at 5 or 8 weeks of age, and then
mated with C57BL/6 male mice. The fertilized oocytes
were collected from females displaying vaginal plugs.
The oocytes were cryopreserved as described above. The
frozen oocytes were thawed and used for microinjection.
Single blastocyst assay
Fertilized oocytes were collected from C57BL/6 supero-
vulated female mice mated with C57BL/6 male mice.
After freeze-thawing of oocytes, FokI-dCas9 vector
Figure 5 Sequence analysis of blastocysts injected with all-in-one FokI-dCas9 vector simultaneously targeting Reg3b and Reg3g genes. The PCR
products were analyzed by direct sequencing to identify mutations in Reg3b (A) and Reg3g (B) loci. The wild-type sequence of Reg3b and Reg3g
are shown at the top (Wild) with the gRNA target sequences (underlined). The PAM sequence is enclosed in red boxes. Deletions are indicated
by dashes. Blastocyst numbers on the left side of each sequence in (A) and (B) are identical. Most blastocysts had multiple types of mutations at
the Reg3b locus. The wild-type Reg3b sequence was not detected in blastocyst #4 and #6. In the other blastocysts, the wild-type Reg3b sequence
was detected along with mutant sequence. Regarding Reg3g locus, the wild-type sequence was detected in all blastocysts with mutant sequence.
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injection was performed. Survival oocytes were cultured in
potassium simplex optimized medium with amino acids
(KSOM-AA) at 37°C in 5% CO2 and 95% humidified air for
3.5 days. For PCR of single blastocysts, 1 μl of KSOM-AA
containing 1 blastocyst was transferred to the wall near the
bottom of a 0.2-mL PCR tube. Blastocyst lysates were pre-
pared by an alkaline lysis method. To detect the targeted
IL11 gene, PCR was performed using KOD FX (TOYOBO,
Osaka, Japan) with the primers listed in Additional file 5
under the following conditions: 94°C for 2 min; followed by
40 cycles of 98°C for 10 s, 60°C for 30 s, and 68°C for 25 s.
Each PCR product was subjected to automatic electrophor-
esis using MultiNA (Shimadzu Corporation, Kyoto, Japan).
The PCR products were purified and analyzed by direct
sequencing, and then the products harboring mutations
were subcloned into pTA2 vector using a Target Clone
-Plus- (TOYOBO). Sequencing was performed using an
ABI 3130 Genetic Analyzer (Life Technologies, Carlsbad,
CA, USA) with a BigDye Terminator v1.1 Cycle Sequen-
cing Kit (Life Technologies). Also for Reg3b and Reg3g,
PCR was performed using KOD FX with the primers
listed in Additional file 5. Subsequently, automaticelectrophoresis and direct sequencing were performed
as described above.
Microinjection and transfer
Each CRISPR/Cas9-plasmid DNA was diluted in DNase-
free PBS at 5 ng/μl for microinjection. The plasmid
DNA was injected into the pronucleus of fertilized oo-
cytes. The injected oocytes were cultured in KSOM-AA
at 37°C in 5% CO2 and 95% humidified air for 1 h. Surviv-
ing oocytes were transferred to the oviducts of pseudopreg-
nant ICR female mice.
Mutation analysis of the IL11 gene
Tail lysates were prepared by an alkaline lysis method
and PCR was performed using KOD FX and the primers
listed in Additional file 5 under the following conditions:
94°C for 2 min; followed by 38 cycles of 98°C for 10 s,
60°C for 30 s, and 68°C for 25 s. Each PCR product was
analyzed by direct sequencing as described above.
Transgene analysis
To examine integration of vector DNA, we designed
primers for Cas9, dCas9, and FokI. Each founder was
Nakagawa et al. BMC Biotechnology  (2015) 15:33 Page 9 of 10examined the integration of Cas9 or dCas9, and FokI by
genomic PCR using KOD FX and the primers listed in
Additional file 5. The PCR products were analyzed by
automatic electrophoresis using MultiNA.
Off-target analysis
Candidates for off-target sequences were selected with the
CRISPR Design tool (http://crispr.mit.edu/) (Additional
file 3). Genomic regions around the top three potential
off-target sites were amplified by PCR from founders using
KOD FX, the primers used are listed in Additional file 5.
Additional files
Additional file 1: Summary of the results of freeze-thawing in
C57BL/6 mice.
Additional file 2: Mutation analysis of PCR products from founders.
Sequence analysis of PCR products from founders injected with
Nuclease_A (A), Nuclease_B (B), Nickase_BC (C), and FokI-dCas9_BD (D,E)
vectors. Founder numbers are shown on the left side. IA, IB, and IBD were
generated from oocytes fertilized by IVF. MA, MB, MBC, and MBD were
generated from oocytes fertilized by mating. 8W were generated from
oocytes of mature females by mating. The wild-type IL11 sequence is
shown at the top (Wild) with the gRNA target sequences (underlined).
The PAM sequence is enclosed in a red box. Deletions are indicated by
dashes, and insertions or substitutions are enclosed in a black box. The
exon 3 sequence is enclosed in a blue box.
Additional file 3: Transgene analysis of founders. (A) Schematic
drawing of the primers for each Cas9 variant. Red bars indicate primers
for FokI detection. Blue bars indicate primers for Cas9 or dCas9 detection.
The lengths of PCR products for FokI and Cas9/dCas9 are 395 and
473 bp, respectively. (B) Pseudo-gel images of transgene analysis. When
vector DNA was integrated, a band of approximately 473-bp or 395-bp
appears. Founder numbers shown on the upper side of each image are
identical to Additional file 2. Red circles indicate transgene-positive
founders. A P, B P, BC P, and BD P indicate positive controls for PCR
amplification with Nulcease_A, Nuclease_B, Nickase_BC, and FokI-dCas9_BD
plasmids, respectively, as templates. M, molecular weight maker (pGEM DNA
Markers; Promega, Madison. WI, USA). W, negative control using founders
without vector injection. N, negative control without template DNA.
Additional file 4: Top three candidates for potential off-target sites
(5’-3’).
Additional file 5: Primer sets for PCR.
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